Moreover, to assess whether PIP/56-1 or PIP/56-2 treatment affects the expression of other EVI1-target genes, we analyzed the expression profile of EVI1high AML cells treated with PIP/56-1. The gene discussed is MECOM; the disease is acute myeloid leukemia.